These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 12850364)

  • 21. Kinetics of the neutralizing antibody response to respiratory syncytial virus infections in a birth cohort.
    Sande CJ; Mutunga MN; Okiro EA; Medley GF; Cane PA; Nokes DJ
    J Med Virol; 2013 Nov; 85(11):2020-5. PubMed ID: 23983183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.
    Fuentes S; Hahn M; Chilcote K; Chemaly RF; Shah DP; Ye X; Avadhanula V; Piedra PA; Golding H; Khurana S
    J Infect Dis; 2020 Feb; 221(4):636-646. PubMed ID: 31745552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection.
    Brandenburg AH; Groen J; van Steensel-Moll HA; Claas EC; Rothbarth PH; Neijens HJ; Osterhaus AD
    J Med Virol; 1997 May; 52(1):97-104. PubMed ID: 9131465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.
    Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
    Front Immunol; 2019; 10():706. PubMed ID: 30984206
    [No Abstract]   [Full Text] [Related]  

  • 25.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
    Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults.
    Falsey AR; Walsh EE; Looney RJ; Kolassa JE; Formica MA; Criddle MC; Hall WJ
    J Med Virol; 1999 Oct; 59(2):221-6. PubMed ID: 10459160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Level of maternal respiratory syncytial virus (RSV) F antibodies in hospitalized children and correlates of protection.
    Taleb SA; Al-Ansari K; Nasrallah GK; Elrayess MA; Al-Thani AA; Derrien-Colemyn A; Ruckwardt TJ; Graham BS; Yassine HM
    Int J Infect Dis; 2021 Aug; 109():56-62. PubMed ID: 34118428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.
    Mazur NI; Horsley NM; Englund JA; Nederend M; Magaret A; Kumar A; Jacobino SR; de Haan CAM; Khatry SK; LeClerq SC; Steinhoff MC; Tielsch JM; Katz J; Graham BS; Bont LJ; Leusen JHW; Chu HY
    J Infect Dis; 2019 Jan; 219(1):59-67. PubMed ID: 30107412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D; Phan S; DiStefano DJ; Citron MP; Callahan CL; Indrawati L; Dubey SA; Heidecker GJ; Govindarajan D; Liang X; He B; Espeseth AS
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection.
    Gerretsen HE; Capone S; Vitelli A; Reyes LS; Thompson A; Jones C; Green CA; Pollard AJ; Sande CJ
    Vaccine; 2018 Nov; 36(46):6988-6994. PubMed ID: 30318168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.
    Nyiro JU; Sande C; Mutunga M; Kiyuka PK; Munywoki PK; Scott JA; Nokes DJ
    Vaccine; 2015 Apr; 33(15):1797-801. PubMed ID: 25725445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody.
    Englund JA
    Pediatr Infect Dis J; 1994 May; 13(5):449-53. PubMed ID: 8072835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody.
    Yang DP; Zielinska E; Quiroz J; Madore D; Rappaport R
    Biologicals; 2007 Jun; 35(3):183-7. PubMed ID: 17241789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya.
    Nyiro JU; Sande CJ; Mutunga M; Kiyuka PK; Munywoki PK; Scott JA; Nokes DJ
    PLoS One; 2016; 11(11):e0166706. PubMed ID: 27851799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults.
    Falsey AR; Walsh EE
    J Infect Dis; 1998 Feb; 177(2):463-6. PubMed ID: 9466538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques.
    Brock LG; Liu X; Liang B; Lingemann M; Liu X; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection.
    Forster J; Maier O; Löbbert J; Kaufmehl K; Streckert HJ; Werchau H
    Infection; 1996; 24(6):407-11. PubMed ID: 9007586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypergammaglobulinemia and Impaired Transplacental Transfer of Respiratory Syncytial Virus Antibody in Papua New Guinea.
    Atwell JE; Thumar B; Formica MA; Robinson LJ; Walsh EE; King CL; Karron RA
    Pediatr Infect Dis J; 2019 Sep; 38(9):e199-e202. PubMed ID: 31408055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.